SCHEMBL9424699

SCHEMBL9424699

CCc1ccc(S(=O)(=O)NC(=O)Nc2ccc(Cl)c(Cl)c2)s1.[NaH]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.48
EPHX2 P34913 2/20 0.48
CYP3A4 P08684 1/20 0.46
CA2 P00918 3/20 0.45
CA9 Q16790 2/20 0.45
CA4 P22748 1/20 0.45
CA5A P35218 1/20 0.45
MEN1 O00255 6/20 0.45
KMT2A Q03164 6/20 0.45
MAPT P10636 5/20 0.45
LMNA P02545 4/20 0.44
HTT P42858 3/20 0.44
NPC1 O15118 2/20 0.44
ADORA3 P0DMS8 1/20 0.44
CHRM1 P11229 1/20 0.44
SLC6A2 P23975 1/20 0.44
PDE4A P27815 1/20 0.44
ADRA1A P35348 1/20 0.44
OPRM1 P35372 1/20 0.44
PDE3A Q14432 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9424554 0.99 EPHX1 (0.49) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL9424703 0.98 EPHX1 (0.48) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL9424464 0.87 KMT2A (0.47) CYP3A4CA2CA9MEN1KMT2A
SCHEMBL9424478 0.85 KMT2A (0.48) CYP3A4CA2CA9MEN1KMT2A
SCHEMBL9424859 0.84 EPHX1 (0.51) EPHX1EPHX2CA2CA9CA4
SCHEMBL9424579 0.83 EPHX1 (0.53) EPHX1EPHX2CA2CA9CA4
SCHEMBL9424863 0.82 MAPT (0.53) EPHX1EPHX2CA2CA9CA4
SCHEMBL9424316 0.81 FBP1 (0.52) EPHX1EPHX2CYP3A4CA2CA9
SCHEMBL9424704 0.78 ALDH1A1 (0.44) CYP3A4CA2CA9MEN1KMT2A
SCHEMBL9424688 0.77 EPHX1 (0.51) EPHX1EPHX2CA2CA9CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5302724-A Thiophenesulfonylureas; anticarcinogenic agents ELI LILLY AND COMPANY (US) 1994-04-12 US disclosed
EP-0467613-A1 Antitumor compositions and methods of treatment ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed